CRVS CORVUS PHARMACEUTICALS
Health Care · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about CORVUS PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8070
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8045
Recent analyst activity · last 90 days
Our tracked history has 3 reports on CRVS from 3 analyst firms in the last 90 days (10 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it.
Latest observed target change: Mizuho lowered its target from $30.00 (set 12 Jun 2026) to $27.00 on 29 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Etzer Darout | Buy | 7 Aug 2026 | 28.00 USD |
| Cantor Fitzgerald | Li Watsek | Buy | 16 Sep 2026 | — |
| Goldman Sachs | Paul Choi | Buy | 17 Apr 2026 | 40.00 USD |
| H.C. Wainwright | Sean Lee | Buy | 15 May 2026 | 27.00 USD |
| Jefferies | Roger Song | Buy | 22 Jan 2026 | 42.00 USD |
| Ladenburg Thalmann | Kevin M Degeeter | Buy | 30 Jul 2026 | 32.00 USD |
| Mizuho | Graig Suvannavejh | ConflictConflicting reports · excluded | 29 Oct 2026 | 27.00 USD |
| Oppenheimer | Jeff Jones | Buy | 13 Mar 2026 | 33.00 USD |
| Weiss Ratings | Unnamed analyst | — | 26 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:14 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.